Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C

Article English OPEN
Livingston, Stephen E.; Bruden, Dana J.T.; Townshend-Bulson, Lisa J.; Homan, Chriss E.; Gove, James E.; Plotnik, Julia N.; Spradling, Philip R.; McMahon, Brian J.; Simons, Brenna C.;
(2016)
  • Publisher: Co-Action Publishing
  • Journal: International Journal of Circumpolar Health,volume 75 (issn: 1797-237X, eissn: 1239-9736)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC4814572, doi: 10.3402/ijch.v75.30696
  • Subject: viral hepatitis | Pegylated interferon, discontinuation, indigenous population, longitudinal study, sustained virologic response. | pegylated interferon | longitudinal study | indigenous population | RC955-962 | discontinuation | clinical investigation; infectious disease; | Original Research Article | sustained virologic response | Arctic medicine. Tropical medicine
    mesheuropmc: digestive system diseases | virus diseases

Background. There have been few reports of hepatitis C virus (HCV) treatment results with interferon-based regimens in indigenous populations.Objective. To determine interferon-based treatment outcome among Alaska Native and American Indian (AN/AI) population.Design. In... View more